Cytology was once a low-attention area of IVD. This is no longer the case. FISH testing is one of the fastest growing categories in in vitro diagnostics. Kalorama has observed this trend over the past decade. Abbott has remained competitive here, but new types of testing products will be the important determinant of future growth. Today's news finds an example of an approval of an Abbott leukemia probe kit.
FDA Clears Genetic FISH Panel